VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EXEL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EXELExelixis, Inc.
$69.57$17.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEXELCash Flow

Exelixis, Inc. (EXEL) Cash Flow Statement

27Y historyFree accessUpdated daily

Free cash flow totaled roughly $277.5M in 2026Q3 with a 42.1% FCF margin, but quarterly FCF margins ranged from 8.0% to 89.0% and cumulative buybacks of roughly $1.6B suggest capital returns are the primary use of cash.

Income StatementBalance SheetCash FlowRatios

EXEL Cash Flow Statement

Annual statement

EXEL Cash Flow Statement

Exelixis, Inc. (EXEL) cash flow statement — 27-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMJan'26Jan'25Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Cash from Operations1.17B884.27M699.97M333.32M362.61M400.8M208.98M526.96M415.72M165.61M206.3M-141.59M-235.41M-198.77M-123.15M-159.23M-101.05M-14.59M-9.76M-68.74M-45.34M-46.36M-93.84M-79.24M-30.92M-23.77M-12.87M-7.3M
Operating CF Margin %-38.11%32.28%18.21%22.51%27.93%21.16%54.45%48.69%36.6%107.75%-380.89%-937.46%-634.29%-259.53%-54.98%-54.61%-9.61%-8.28%-60.58%-45.95%-61.03%-177.53%-153.74%-69.77%-57.96%-51.97%-69.52%
Operating CF Growth %582.49%26.33%110%-8.08%-9.53%91.79%-60.34%26.76%151.02%-19.72%245.7%39.85%-18.43%-61.41%22.66%-57.58%-592.54%-49.54%85.81%-51.61%2.2%50.59%-18.42%-156.23%-30.11%-84.72%-76.26%-
Net Income885.14M782.57M521.27M207.76M182.28M231.06M111.78M321.01M690.07M154.23M-70.22M-169.74M-268.54M-244.76M-147.65M75.7M-92.33M-139.56M-162.85M-86.38M-101.49M-84.4M-137.25M-94.77M-86.13M-71.19M-75.31M-18.7M
Depreciation & Amortization27.81M29.05M28.8M25.72M20.88M13.63M9.14M8.35M7.77M1.19M1M1.41M2.39M3.15M5.72M6.82M10.54M12.6M13.23M11.33M16.91M17.75M17.49M17.75M16.7M15.21M18.86M5.7M
Stock-Based Compensation110.43M112.98M93.84M106.34M107.57M119.82M105.07M56.6M44.32M23.94M22.91M21.98M10.01M12.03M8.83M12.1M21.11M22.91M0017.61M110K56K2.46M0000
Deferred Taxes0126.24M-59.46M-133.21M-60.36M46.53M15.27M71M-244.11M3.26M11.41M436K-2.68M0-950K-77.45M-4.87M7.77M00-39.29M-110K-56K-2.46M0000
Other Non-Cash Items159.76M24.62M128.98M140.68M125.04M28.77M7.87M2.91M-2.57M-10.05M13.93M30.18M33.7M33.08M19.54M88.49M6.83M1.62M6.57M-40.46M18.37M-9.63M26.86M1.53M3.66M16.7M38.02M0
Working Capital Changes-10.08M-191.2M-13.45M-13.97M-12.8M-39.01M-40.14M67.08M-79.76M-6.95M227.27M-25.84M-10.28M-2.27M-8.64M-264.88M-42.33M80.07M133.3M46.77M42.55M29.92M-947K-3.74M34.84M15.51M5.57M5.7M
Change in Receivables-18.74M-21.4M-27.95M-22.62M66.85M-122.32M-42.47M43.72M-85.47M-40.84M-37M-646K-941K8.49M27.04M0000000000000
Change in Inventory10.05M12.22M5.45M-12.98M-11.68M-13.21M-21.9M-5.73M-3.18M-3.32M-722K-235K509K-2.89M00000000000041K0
Change in Payables90K-50.15M-21.89M50.11M23.36M55.09M50.51M39.69M856K3.01M164K-1.28M-13.21M8.69M6.32M-5.55M-9.44M00012.16M355K764K-3.38M0000
Cash from Investing60.89M350.44M-116.78M-26.95M-524.41M-42.88M-131.22M-587.25M-297.85M35.8M-216.05M50.08M146.33M144.35M-259.47M-51.46M-19.57M-112.32M121.37M-3.02M-21.7M-36.07M20.46M-14.6M46.81M5.41M-96.44M-6.5M
Capital Expenditures-11.97M-8.43M-28.43M-40.47M-27.71M-54.23M-30.34M-12.83M-33.3M-21.14M-1.7M-447K-474K-2.17M-2.72M-991K-1.81M-5.91M-15.13M-17.4M-11.61M-14.36M-12.34M-14.25M-5.85M-9.09M-15.39M-5M
CapEx % of Revenue0.48%0.36%1.31%2.21%1.72%3.78%3.07%1.33%3.9%4.67%0.89%1.2%1.89%6.93%5.73%0.34%0.98%3.89%12.84%15.33%11.77%18.9%23.34%27.64%13.2%22.18%62.14%47.62%
Acquisitions00000000308K164K2.49M95K838K143K1.94M3.01M9M2.2M9M35.31M10K186K-1.6M00000
Investments----------------------------
Other Investing-16.6M-31.5M-37.75M-122.5M-110.75M-10M00308K-1M-1.4M15.48M12.6M11.18M-35.99M1.53M165K-2.43M3.22M2.4M3.05M-30.68M-11.2M-4.84M-5.76M8.83M10.08M0
Cash from Financing-1.31B-969.59M-628.81M-546.05M586K-14.8M-25.13M12.55M9.69M-169.93M19.8M152.75M65.49M-11.67M478.43M187.51M131.26M-33.99M630K84.25M109.34M100.93M39.65M114.67M32.63M34.35M123.46M17.1M
Debt Issued (Net)00000000-13K-185.79M-7.71M-4.38M-11.71M-13.17M272.8M-6.03M125.44M-38.06M-3.83M490K-27.2M1.49M34.59M37.1M24.8M21.43M-2.77M8.3M
Equity Issued (Net)-1.23B-898.37M-590.18M-516.93M23.89M000000157.13M75.64M0203.48M179.38M03.83M4.15M83.76M96.54M62.44M5.06M76.83M6.83M12.93M125.93M8.9M
Dividends Paid0000000000000000000000000000
Share Repurchases-1.26B-947.51M-652.03M-550.38M0000-7.57M-6.56M-4.11M00000000000000000
Other Financing-78.76M-71.22M-38.63M-29.12M-23.3M-14.8M-25.13M12.55M9.7M15.86M23.41M01.56M1.5M2.15M14.17M5.82M248K310K040M37M0733K995K0297K-100K
Net Change in Cash-71.53M265.11M-45.62M-239.68M-161.21M343.12M52.63M-47.74M127.56M31.48M10.05M61.24M-23.58M-66.09M95.81M-23.18M10.64M-160.9M112.24M12.09M42.04M18.37M-33.72M21.55M48.94M16.03M14.15M3.3M
Free Cash Flow1.15B844.34M633.79M170.35M224.16M336.58M178.64M514.12M382.42M144.47M204.59M-142.03M-235.88M-200.94M-125.86M-160.22M-102.86M-20.5M-24.89M-86.14M-56.95M-60.72M-106.17M-93.48M-36.77M-32.86M-28.25M-12.3M
FCF Margin %46.14%36.39%29.22%9.31%13.91%23.46%18.09%53.12%44.79%31.93%106.86%-382.09%-939.35%-641.22%-265.25%-55.32%-55.59%-13.51%-21.12%-75.91%-57.72%-79.93%-200.87%-181.38%-82.97%-80.14%-114.11%-117.14%
FCF Growth %54.79%33.22%272.04%-24%-33.4%88.42%-65.25%34.44%164.71%-29.39%244.05%39.79%-17.39%-59.65%21.45%-55.77%-401.78%17.64%71.11%-51.25%6.21%42.81%-13.57%-154.21%-11.91%-16.31%-129.7%-
FCF per Share4.503.002.140.530.691.040.561.631.220.460.82-0.68-1.21-1.09-0.79-1.23-0.95-0.19-0.24-0.87-0.66-0.77-1.46-1.43-0.65-0.71-0.91-2.08
FCF Conversion (FCF/Net Income)1.30x1.13x1.34x1.60x1.99x1.73x1.87x1.64x0.60x1.07x-2.94x0.83x0.88x0.81x0.83x-2.10x1.09x0.11x0.06x0.80x0.45x0.55x0.68x0.84x0.36x0.33x0.17x0.39x
Interest Paid00000000020.46M21.04M19.82M19.11M06.98M0000000000000
Taxes Paid0155.3M170.48M185.66M127.87M12.96M4.12M7.87M10.68M538K190K192K60K01.12M0000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityStrong
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Lumpy operating cash conversion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Operating Cash Conversion Swings Sharply by Quarter

Based on Exelixis's reported figures, operating cash flow to net income ranged from 0.27 in 2025Q2 to 2.64 in 2026Q2, a spread that points to working capital timing rather than a stable earnings-to-cash relationship over the period.

Across the ten reported quarters, operating cash flow has frequently exceeded net income, with the ratio averaging well above 1.0, which generally suggests non-cash charges and favorable working capital movements are supporting reported earnings. The 2025Q2 quarter, where operating cash flow fell to $49.0M against $184.8M of net income, coincides with a $180.3M working capital outflow, indicating that timing of receivables or payables rather than underlying earnings weakness drove the gap. Investors should monitor whether the 2026Q2 spike, which included a $42.3M working capital contribution and $61.6M of stock-based compensation add-back, reflects durable cash generation or a temporary benefit that may reverse.

Free Cash Flow Margins Remain Volatile

As reported in financial statements, Exelixis's free cash flow margin moved between 8.0% in 2025Q2 and 89.0% in 2026Q2, with the trailing pattern showing no clear directional trend across the observed quarters.

Free cash flow has been largely driven by operating cash flow since CapEx is minimal, with capital expenditures running below 1.5% of revenue in recent quarters, so FCF volatility mirrors working capital swings rather than investment needs. The 2026Q3 free cash flow of $277.5M on a 42.1% margin is solid but sits below the 2026Q2 peak, suggesting the business is generating strong cash on a normalized basis without clear acceleration. Given that reported net income of $218.1M is largely converted to free cash flow in recent quarters, the cash profile appears tied to a mature, high-margin revenue base.

Asset-Light Model Limits Reinvestment Needs

According to recent SEC filings, Exelixis's capital expenditures have declined from 1.5% of revenue in 2024Q3 to 0.2% in 2026Q1, reflecting a business with very low physical capital requirements.

Capital intensity is minimal, and the depreciation and amortization of roughly $7M per quarter is far below operating cash flow, indicating that maintenance reinvestment is not a material drain on cash. The steady decline in CapEx suggests that the company is not currently funding meaningful growth in physical infrastructure, which is consistent with a royalty and licensing-driven model. This low reinvestment profile means that cash generated is largely available for capital deployment decisions, though it also means the business relies on intellectual property and partnerships rather than tangible asset expansion.

Buybacks Dominate Capital Allocation Choices

Based on Exelixis's reported figures, share repurchases totaled roughly $1.6B across recent quarters, with no dividends paid, making buybacks the primary use of free cash flow over the period.

Exelixis has directed substantial free cash flow toward repurchasing shares, including $753.3M in 2026Q2 and $430.4M in 2026Q1, which exceeds free cash flow in several quarters and suggests the company is drawing on accumulated cash or prior cash generation. The absence of dividends and reliance on buybacks indicates management is prioritizing per-share value accretion over income distribution. Investors should monitor whether repurchase pacing remains sustainable relative to the lumpy cash generation profile, since buybacks exceeding free cash flow in certain quarters may reduce financial flexibility if operating cash conversion weakens.

Cumulative Cash Generation Tracks Earnings Closely

Across the ten reported quarters, cumulative operating cash flow of roughly $2.2B compares with cumulative net income of roughly $1.9B, suggesting cash has broadly kept pace with reported earnings over this window.

The cumulative gap between operating cash flow and net income is positive over the observed period, which argues against a pattern of earnings running ahead of cash. However, the window covers only ten quarters, so this conclusion is limited and may not capture longer-cycle royalty or milestone timing effects. Analysts should consider whether the favorable cumulative relationship holds over a longer horizon before treating current cash conversion as structurally reliable.

Quarterly Strength May Mask Timing Dependence

The cash flow statement may obscure how much recent strength depends on working capital timing and stock-based compensation add-backs, which together account for a large share of several headline quarters.

Stock-based compensation of roughly $20M to $62M per quarter is a non-cash add-back that lifts operating cash flow without consuming cash, so the reported conversion ratios partly reflect accounting treatment rather than cash earned from operations. Several of the strongest quarters, including 2026Q2, coincide with large positive working capital contributions that may reverse, and the available data does not show the receivable or royalty payment schedules needed to judge that reversal risk. Investors should therefore treat the cumulative cash conversion figure with caution and monitor whether underlying cash generation holds once timing effects normalize.

EXEL — Frequently Asked Questions

Quick answers to the most common questions about buying EXEL stock.

How much cash does Exelixis, Inc. (EXEL) generate from operations?

Exelixis, Inc. (EXEL) generated $884.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Exelixis, Inc.'s free cash flow?

Exelixis, Inc. (EXEL) generated $844.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Exelixis, Inc.'s capital expenditure (CapEx)?

Exelixis, Inc. (EXEL) spent $8.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Exelixis, Inc. distribute cash to shareholders?

In 2025, Exelixis, Inc. (EXEL) spent $947.5M on share repurchases. This shows the company's commitment to returning capital to its equity investors.